MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Caspr2 antibody associated spinal myoclonus

    S. Duma, V. Fung, R. Dhanapalaratnam, A. Martin, T. Ong, L. Allport (Kogarah, Australia)

    Objective: We report two patients with spinal myoclonus and Contactin-associated protein-2 (Caspr-2)-antibodies, idiopathic in one and paraneoplastic in the other. Background: Caspr-2-antibodies have classically been…
  • MDS Virtual Congress 2020

    Large-Scale Network Changes in the Pathophysiology of Essential Tremor

    A. Morris, S. Norris, B. Adeyemo, S. Petersen, A. Snyder, J. Mink, J. Perlmutter (Rochester, NY, USA)

    Objective: To assess functional brain network architecture in participants with medically-refractory essential tremor (ET) and to correlate the strength of these networks with clinical tremor…
  • MDS Virtual Congress 2020

    Differential Diagnosis Between Functional Facial Spasm and Hemifacial Spasm: Role of Blink Reflex

    V. Oppo, G. Cossu, J. Valls-Solé, M. Edwards, F. Morgante (Cagliari, Italy)

    Objective: We aimed to test the value of Blink Reflex (BR) as an electrophysiological tool in differentiating functional facial spasm (F-FS) from hemifacial spasm (HFS).…
  • MDS Virtual Congress 2020

    Cost-Utility Analysis of Flexible Intervals with IncobotulinumtoxinA Versus Fixed Dosing with OnabotulinumtoxinA in the Management of Cervical Dystonia and Blepharospasm in Major Canadian Markets

    M.E Gendron, R. Kazerooni, D. Vézina (Burlington, ON, Canada)

    Objective: The aim was to carry out a cost-utility analysis for IncobotulinumtoxinA (INCO) administered with flexible treatment intervals compared to onabotulinumtoxinA (ONA) administered with fixed…
  • MDS Virtual Congress 2020

    On Time, Every Time: The Effect of Cohort Ward Triage, Specialist Nursing & Admission Pre-Alert on Parkinson’s Medication Management

    S. Moore, A. Yousuf, S. Jackson (Exeter, United Kingdom)

    Objective: To explore whether implementing dedicated cohort warding, specialist nursing and acute admission pre-alert improves the medication management of patients with Parkinson’s (PwP). Background: Previous…
  • MDS Virtual Congress 2020

    Are oromotor deficits a late stage signs in Parkinson’s disease?

    P.U Upadhyay, S.G Gudwani, K.S Sharma, S.K Kumaran, R.S Sagar, R.D Dhamija (New Delhi, India)

    Objective: To assess any preclinical signs of dysphagia in early PD. Background: Pre-clinical stages of Parkinson’s disease (PD) include the subtle signs of autonomic dysfunction,…
  • MDS Virtual Congress 2020

    Relationship Between a-syn RT-QuIC and a-syn Neuropathologic Burden in Dementia with Lewy Bodies

    D. Coughlin, C. Orru, B. Groveman, A. Hiniker, R. Rissman, B. Caughey, D. Galasko (San Diego, CA, USA)

    Objective: To determine if measures of alpha-synuclein (a-syn) real time quaking induced conversion (RT-QuIC) activity are related to a-syn neuropathologic burden in dementia with Lewy…
  • MDS Virtual Congress 2020

    Exploring cognitive aspect of linguistic prosody in Parkinson’s disease

    A. Basirat, S. Pinto, K. Dujardin, L. Defebvre, D. Devos, C. Moreau (Lille, France)

    Objective: To explore the correlation between linguistic prosody and cognition in Parkinson's disease Background: Around 90% of patients with Parkinson’s disease (PD) report speech deficit.…
  • MDS Virtual Congress 2020

    Modifiable Comorbidities Associated with Rate of Cognitive Decline in Parkinson’s Disease

    E. Forbes, T. Tropea, S. Mantri, J. Morley (Philadelphia, PA, USA)

    Objective: To determine the association between baseline modifiable comorbidities, including cardiovascular disease risk factors, mood disorders, and sleep characteristics, and the rate of change in…
  • MDS Virtual Congress 2020

    Both Symptomatic and Asymptomatic Orthostatic Hypotension is Associated with Cognitive Decline Over Time in Parkinson’s Disease

    K. Longardner, E. Bayram, I. Litvan (San Diego, CA, USA)

    Objective: To compare cognitive changes over time between Parkinson's disease (PD) patients with orthostatic hypotension (OH) and without OH, and between those with symptomatic OH…
  • « Previous Page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley